Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 188

Similar articles for PubMed (Select 20126658)

1.

Biochemical profiling of histone binding selectivity of the yeast bromodomain family.

Zhang Q, Chakravarty S, Ghersi D, Zeng L, Plotnikov AN, Sanchez R, Zhou MM.

PLoS One. 2010 Jan 26;5(1):e8903. doi: 10.1371/journal.pone.0008903.

2.

Partners in crime: The role of tandem modules in gene transcription.

Sharma R, Zhou MM.

Protein Sci. 2015 Jun 8. doi: 10.1002/pro.2711. [Epub ahead of print]

PMID:
26059070
3.

dbHiMo: a web-based epigenomics platform for histone-modifying enzymes.

Choi J, Kim KT, Huh A, Kwon S, Hong C, Asiegbu FO, Jeon J, Lee YH.

Database (Oxford). 2015 Jun 8;2015. pii: bav052. doi: 10.1093/database/bav052. Print 2015.

4.

A sensitive protein-based sensor for quantifying histone acetylation levels.

Sanchez OF, Williamson D, Cai L, Yuan C.

Talanta. 2015 Aug 1;140:212-8. doi: 10.1016/j.talanta.2015.03.046. Epub 2015 Mar 28.

PMID:
26048844
5.

Binding Mode of Acetylated Histones to Bromodomains: Variations on a Common Motif.

Marchand JR, Caflisch A.

ChemMedChem. 2015 Jun 1. doi: 10.1002/cmdc.201500141. [Epub ahead of print]

PMID:
26033856
6.

Discovery of a Chemical Tool Inhibitor Targeting the Bromodomains of TRIM24 and BRPF.

Bennett J, Fedorov O, Tallant C, Monteiro O, Meier J, Gamble V, Savitsky P, Nunez-Alonso GA, Haendler B, Rogers C, Brennan PE, Müller S, Knapp S.

J Med Chem. 2015 May 20. [Epub ahead of print]

PMID:
25974391
7.

Structural diversity of the epigenetics pocketome.

Cabaye A, Nguyen KT, Liu L, Pande V, Schapira M.

Proteins. 2015 May 13. doi: 10.1002/prot.24830. [Epub ahead of print]

PMID:
25974248
8.

An aromatic cage is required but not sufficient for binding of Tudor domains of the Polycomblike protein family to H3K36me3.

Gatchalian J, Kingsley MC, Moslet SD, Rosas Ospina RD, Kutateladze TG.

Epigenetics. 2015 Jun 3;10(6):467-73. doi: 10.1080/15592294.2015.1042646. Epub 2015 Apr 29.

PMID:
25923537
9.

Identification of lysine-acetylated mitochondrial proteins and their acetylation sites.

Hartl M, König AC, Finkemeier I.

Methods Mol Biol. 2015;1305:107-21. doi: 10.1007/978-1-4939-2639-8_7.

PMID:
25910729
10.

Emerging therapeutic targets in human acute myeloid leukemia (part 2) - bromodomain inhibition should be considered as a possible strategy for various patient subsets.

Reikvam H, Hoang TT, Bruserud Ø.

Expert Rev Hematol. 2015 Jun;8(3):315-27. doi: 10.1586/17474086.2015.1036025. Epub 2015 Apr 22.

PMID:
25901742
11.

Histone Acylation beyond Acetylation: Terra Incognita in Chromatin Biology.

Rousseaux S, Khochbin S.

Cell J. 2015 Spring;17(1):1-6. Epub 2015 Apr 8. Review.

12.

LP99: Discovery and Synthesis of the First Selective BRD7/9 Bromodomain Inhibitor.

Clark PG, Vieira LC, Tallant C, Fedorov O, Singleton DC, Rogers CM, Monteiro OP, Bennett JM, Baronio R, Müller S, Daniels DL, Méndez J, Knapp S, Brennan PE, Dixon DJ.

Angew Chem Int Ed Engl. 2015 May 18;54(21):6217-21. doi: 10.1002/anie.201501394. Epub 2015 Apr 13.

13.

Discovery of I-BRD9, a Selective Cell Active Chemical Probe for Bromodomain Containing Protein 9 Inhibition.

Theodoulou NH, Bamborough P, Bannister AJ, Becher I, Bit RA, Che KH, Chung CW, Dittmann A, Drewes G, Drewry DH, Gordon L, Grandi P, Leveridge M, Lindon M, Michon AM, Molnar J, Robson SC, Tomkinson NC, Kouzarides T, Prinjha RK, Humphreys PG.

J Med Chem. 2015 Apr 30. [Epub ahead of print]

PMID:
25856009
14.

Bromodomains shake the hegemony of pan-acetyl antibodies.

Champleboux M, Govin J.

Proteomics. 2015 May;15(9):1457-8. doi: 10.1002/pmic.201500116.

15.

Discovery and Characterization of GSK2801, a Selective Chemical Probe for the Bromodomains BAZ2A and BAZ2B.

Chen P, Chaikuad A, Bamborough P, Bantscheff M, Bountra C, Chung CW, Fedorov O, Grandi P, Jung D, Lesniak R, Lindon M, Müller S, Philpott M, Prinjha R, Rogers C, Selenski C, Tallant C, Werner T, Willson TM, Knapp S, Drewry DH.

J Med Chem. 2015 Apr 6. [Epub ahead of print]

PMID:
25799074
16.

Identification of key binding site residues of MCT1 for AR-C155858 reveals the molecular basis of its isoform selectivity.

Nancolas B, Sessions RB, Halestrap AP.

Biochem J. 2015 Apr 1;467(1):192. No abstract available.

PMID:
25793420
17.

Investigation of the β-sheet interactions between dHP1 chromodomain and histone 3.

Eisert RJ, Kennedy SA, Waters ML.

Biochemistry. 2015 Apr 14;54(14):2314-22. doi: 10.1021/acs.biochem.5b00024. Epub 2015 Apr 1.

PMID:
25790265
18.

Identification of Covalent Bromodomain Binders through DNA Display of Small Molecules.

Daguer JP, Zambaldo C, Abegg D, Barluenga S, Tallant C, Müller S, Adibekian A, Winssinger N.

Angew Chem Int Ed Engl. 2015 May 11;54(20):6057-61. doi: 10.1002/anie.201412276. Epub 2015 Mar 13.

PMID:
25772490
19.

Insight into the key interactions of bromodomain inhibitors based on molecular docking, interaction fingerprinting, molecular dynamics and binding free energy calculation.

Ran T, Zhang Z, Liu K, Lu Y, Li H, Xu J, Xiong X, Zhang Y, Xu A, Lu S, Liu H, Lu T, Chen Y.

Mol Biosyst. 2015 May;11(5):1295-304. doi: 10.1039/c4mb00723a.

PMID:
25758752
20.

Small-molecule BET inhibitors in clinical and preclinical development and their therapeutic potential.

Yu L, Wang Z, Zhang Z, Ren X, Lu X, Ding K.

Curr Top Med Chem. 2015;15(8):776-94.

PMID:
25732788
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk